Alpha Healthcare Acquisition Corp. III
We intend to focus our search on companies in the healthcare industry.
Our management team is led by Rajiv Shukla, our Chairman and Chief Executive Officer, and Patrick A. Sturgeon, our Chief Financial Officer.
Rajiv Shukla has been our Chairman and Chief Executive Officer since inception and has two decades of buyouts, investments and operations experience in the healthcare industry. Mr. Shukla serves as Chairman and Chief Executive Officer of Alpha Healthcare Acquisition Corp. (“AHAC”), a Nasdaq-listed special purpose acquisition company which raised $100 million in its initial public offering in September 2020. In February 2021, AHAC announced the signing of a definitive agreement to acquire Humacyte, Inc. (“Humacyte”), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, together with a concurrent $175 million private placement from fundamental healthcare investors.
(Note: Alpha Healthcare Acquisition III priced its SPAC IPO on July 26, 2021, in line with the terms in its prospectus: 15 million units at $10 each to raise $150 million. This SPAC IPO was initially expected to price in late March.)
|Address||1177 Avenue of the Americas, 5th Floor New York, New York 10036|
|Phone Number||(646) 494-3296|
|View Prospectus:||Alpha Healthcare Acquisition Corp. III|
|Revenues||$0 mil (last 12 months)|
|Net Income||$0 mil (last 12 months)|
|Price range||$10.00 - $10.00|
|Est. $ Volume||$150.0 mil|
|Manager / Joint Managers||BofA Securities/PJT Partners|
|Expected To Trade:||7/27/2021|
|Quiet Period Expiration Date:||Available only to Subscribers|
|Lock-Up Period Expiration Date:||Available only to Subscribers|
|SCOOP Rating||Available only to Subscribers|
|Rating Change||Available only to Subscribers|